| Tag | Content |
|---|
EnhancerAtlas ID | HS098-44955 |
Organism | Homo sapiens |
Tissue/cell | HSMM |
Coordinate | chr5:66143340-66145370 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr5:66144548-66144566 | TTTTCCTTCTTTTCTTCC | - | 6.41 | | Foxd3 | MA0041.1 | chr5:66144282-66144294 | GTTTGTTTGTTT | + | 6.32 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_38498 | chr5:66143371-66146815 | HUVEC | | SE_65087 | chr5:66143546-66148107 | NHEK |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH05I066848 | chr5 | 66144181 | 66148151 |
|
Enhancer Sequence | AATTCCAGAT ACTTGGGAAG TTGAGGCAGG GAGAATTGCT TGAACCCAGG AGGCAGAGGT 60
TGCAGTGAGC TGAAATCATG CCACTGCATT CCAGCCTGGG TGACAGAGCG AGACTCCATC 120
TCAAAAAATA AAACAACAAC AACAACAAAA ACACAAATAT TAGCTGGAGG TGGTGGTGGG 180
AGCCTGTAAT CCCAGCTACT TGGGAGGCTG AGGCACTAGA ATCACTTGAA CTAGGGAGGC 240
GGAAGTTGCA GTGAGCTGAG ATTGTGCCAC TACTCTCCAG CCTGGGTGCT GGAACAAGAC 300
TCCTTCTCAA AAAAAAAAAA AAAAAAAAAA AGAAAAACCT TAACAGTAGC TCAAAGCTAC 360
ACTGGGTGTA TGAAGAAAGA TTGTTTTAGG AAAATGGCAG TGCCGTGAAA GGTGAGGCCA 420
AGACTTGGAA AGAAATCAAG TTCTTACAGC CACTGTAAGG CCACTGGATC AAATGTTGTC 480
CTAAGCAAAA CCTCTTGCTG GACTTTTGTG TTGCCCCAGT GGATAAATCC TTTATATTGT 540
TTAAGTCACT GTGATTTGGG TATTTTGTTA CTTGGAACAA AAAGTATCCT ACTCTTTTGG 600
GGTTTTAATT TGCTTACTAT TTGCTTAAGA TTTTTTTCTT TTGAATATTC AGAAATTTTT 660
ATTTTGGTGT CAAAGTAAAT TTAGTGTATC CCCTTTCTAA AATGTCTTGC TTTTTTTCTT 720
CTACAAAGTT TTCTTATTCT TTGTTATTTT ACAATTAAAA CATGCTTTAT ATGTAAATAA 780
TTTGTTTATG ATGTTAGAAG AGGCAGAAAA AAGGCGATAA GGAATGCAAA TTTATTTCAG 840
TAACATTTGT CATAAAATAC TAAGTTTTTT CTTCTTTGAA GGATTAGTAT ATTTGTGCTT 900
TTACTCTGCT AACCTCTTAA AAGCAGGCAG GTTGTTTTTT TTGTTTGTTT GTTTACTAAG 960
AATTACTAGG CATGACTTCA CCAATGATCA GTTAGCCTCC GTTATTATAA TTTTTTAACC 1020
TAAATGATTT GACAGTGATA AATAGCTGAT GTGGCAAGTC TGCAAAAAGC TTTATATTGT 1080
TATTGCCTTT TATCACTTGT GCTCTAAATA ATTGTTCTCA TCTGTCGACT CTTAGATGCA 1140
GTTTTGTGAG GATTAGGATG TATGGAACAG AAAATCCCGC CTAGTGATTT TTTAAAATTC 1200
TCTATTTCTT TTCCTTCTTT TCTTCCTAGT TTTCTTCCTC TTCTCTCCAG TGTGTTTACT 1260
TATGAAAGTT GTACTCATGA TTTAAGATCC AATTCCATAG ACCCTCTTGC CAGACCACAT 1320
GTATGTCTGT AGCTGCAGCA TTTATACACA TGGCACGAGC AGCTGGGATG TCTGGTGTGC 1380
TCATATCAGA AAACTCTGTC AAACATGTGG AGAGGATTGC CTTTTATGCT GCGTTCCCCA 1440
GCGTTATGCT CTTCCTGCAT CATGAGTTAA AGCGATGGAA TTTTGTCCAG GGTCAGAGCC 1500
TCTGCAAAAC AGGAAACCTG TTGGACTCAG TGAAATAATG ACTCTCAATA TCCCCATTAT 1560
GGATGATTAG GGGTGTCCTT GCTCTAGGTT TCCTTGACTC CTTTATGCAT CTTTGTATTG 1620
TGATGAGGGG GTCATAAGCC AAACTGGGGT TCCATGTCTA GAGGCTGACC CTGTGGCATT 1680
GTTGCAGAGC TGATGGAAAT TTTGGGGGGT TCTGTCTAGT TTTGTCCAGT TTGTTCTATT 1740
CTGGTTCATA CCCCAATTCG AAGCTGAGGA AGCAGGCAGA AACTAGAGTC TATCAAGTCT 1800
TCGCTAAGGA AACATCTGTG CCCTCCTCCT GAGGAGTCTC TCCGTTTGTT GGCTGGTTCT 1860
CCTTCCTTCT GCATCCAGTT CCCTCCTCCT GTCTATTCTC CCCTCCACCT CCCCTTTCCC 1920
CTCTCTCTTT ACCCTACTCC TCTTCTGCTT TCCTCCCCCC TTTTCTCTTC TCCTGTCCTT 1980
TTTCATTTAC TCCATCTCCT CCTTTCCTGG AGTTCACTTG AGCATTTCTT 2030
|
